Drugs Made In America Acquisition II Corp. Ordinary Shares
DMII | NASDAQ
$10.20
$0.00 (0.00%)
At close: Oct 30, 2026, 3:59 PM ET
$10.19
-$0.01 (-0.10%)
After-hours:
Oct 30, 2026, 4:02 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
Revenue | n/a | n/a |
Cost of Revenue | n/a | n/a |
Gross Profit | n/a | n/a |
Operating Income | -1.3M | -151.72K |
Interest Income | 4.93M | n/a |
Pretax Income | 4.19M | -151.72K |
Net Income | 4.19M | -151.72K |
Selling & General & Admin | 488.39K | 151.72K |
Research & Development | n/a | n/a |
Other Expenses | 812.11K | n/a |
Operating Expenses | 1.3M | 151.72K |
Interest Expense | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a |
Cost & Expenses | 1.3M | 151.72K |
Income Tax Expense | n/a | n/a |
Shares Outstanding (Basic) | 13.29M | 63.7M |
Shares Outstanding (Diluted) | 13.29M | 63.7M |
EPS (Basic) | 0.16 | 0 |
EPS (Diluted) | 0.15 | 0 |
EBITDA | -1.3M | -151.72K |
EBIT | -1.3M | -151.72K |
Depreciation & Amortization | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DMII